The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain

Joao Marques, Jangawar Anwar, Signe Eskildsen-Larsen, Dominique Rebouillat, Søren Riis Paludan, Ganes Sen, Bryan R G Williams, Rune Hartmann

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

    56 Citations (Scopus)

    Abstract

    Viral infection of mammalian cells prompts the innate immune system to initiate an antiviral response. The recognition of the virus triggers several antiviral signalling pathways, which among others include the family of 2'-5' oligoadenylate synthetase (OAS) proteins. The p59 protein encoded by the OAS-like (OASL) gene is an atypical member of the OAS family in the sense that it lacks the characteristic 2'-5' oligoadenylate synthetase activity. We decided to investigate the putative antiviral activity of p59 by ectopically expressing this protein in Vero cells and then infecting these cells with virus. We demonstrate that OASL has an antiviral effect against the single-stranded RNA virus picornavirus, encephalomyocarditis virus, but not against a large DNA virus, herpes simplex virus 1. Importantly, this antiviral activity was lost in a truncated version of p59 lacking the ubiquitin-like C-terminal domain of p59. Taken together our results indicate that p59 is indeed an antiviral protein that works through a novel mechanism distinct from other OAS proteins.
    Original languageEnglish
    JournalJournal of General Virology
    Volume89
    IssuePt 11
    Pages (from-to)2767-72
    Number of pages5
    ISSN0022-1317
    DOIs
    Publication statusPublished - 2008

    Fingerprint

    Dive into the research topics of 'The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain'. Together they form a unique fingerprint.

    Cite this